Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression-Reference-Cited by-同舟云学术

Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression

Published:2009-05 Issue:5 Volume:154 Page:688-693
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Patiño-García Ana,Zalacaín Marta,Marrodán Lucía,San-Julián Mikel,Sierrasesúmaga Luis

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference24 articles.

1. RNTI. Registro Nacional de Tumores Infantiles. Instituto de Estudios Documentales e Históricos sobre la Ciencia (CSIC-Universitat de Valencia).

2. Osteosarcoma;Link,1997

3. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup;Lewis;J Natl Cancer Inst,2007

4. Pharmacogenetics of folate-related drug targets in cancer treatment;Robien;Pharmacogenomics,2005

5. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE Review;Sharp;Am J Epidemiol,2004

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis;World Journal of Surgical Oncology;2024-01-11

2. Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines;Archives of Biochemistry and Biophysics;2023-01

3. Methotrexate-Induced Toxicities in Pediatrics with Malignancy: A Systematic Review and Meta-analysis;INT J MED TOX FORENS;2023

4. Impact of Methotrexate-Related Genetic Polymorphisms in High-Dose Methotrexate Therapy for Childhood Acute Lymphoblastic Leukaemia;Advances in Clinical Medicine;2023

5. Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report;Frontiers in Medicine;2022-12-21